Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Lees

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|June 11, 1977
Ethambutol plus isoniazid compared with rifampicin plus isoniazid in antituberculosis continuation treatmentA W Lees, G W Allan, J Smith, et al.
Breast Cancer Research and Treatment|January 1, 1981
Effect of chemotherapy on survival in metastatic breast cancerA H Paterson, O Szafran, F Cornish, et al.
Lancet (London, England)|August 9, 1980
Impact of chemotherapy of survival in metastatic breast cancerA H Paterson, A W Lees, J Hanson, et al.
Lancet (London, England)|May 8, 1971
Endocarditis due to Torulopsis glabrataA W Lees, S S Rao, J A Garret, et al.
American Journal of Clinical Oncology|August 1, 1985
Response to treatment and its influence on survival in metastatic breast cancerA H Paterson, M Cyr, O Szafran, et al.
Canadian Medical Association Journal|September 8, 1979
Five-year survival of women with breast cancer in northern AlbertaP E Burns, K Freund, A W Lees, et al.
Chest|June 1, 1972
Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivationJ Smith, W F Tyrell, A Gow, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1982
Influence and significance of certain prognostic factors on survival in breast cancerA H Paterson, V P Zuck, O Szafran, et al.
The American Review of Respiratory Disease|January 1, 1972
Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosisA W Lees, G W Allan, J Smith, et al.
Surgery, Gynecology & Obstetrics|December 1, 1980
Oophorectomy versus radiation ablation of ovarian function in patients with metastatic carcinoma of the breastA W Lees, C Giuffre, P E Burns, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|June 11, 1977
Ethambutol plus isoniazid compared with rifampicin plus isoniazid in antituberculosis continuation treatmentA W Lees, G W Allan, J Smith, et al.
Breast Cancer Research and Treatment|January 1, 1981
Effect of chemotherapy on survival in metastatic breast cancerA H Paterson, O Szafran, F Cornish, et al.
Lancet (London, England)|August 9, 1980
Impact of chemotherapy of survival in metastatic breast cancerA H Paterson, A W Lees, J Hanson, et al.
Lancet (London, England)|May 8, 1971
Endocarditis due to Torulopsis glabrataA W Lees, S S Rao, J A Garret, et al.
American Journal of Clinical Oncology|August 1, 1985
Response to treatment and its influence on survival in metastatic breast cancerA H Paterson, M Cyr, O Szafran, et al.
Canadian Medical Association Journal|September 8, 1979
Five-year survival of women with breast cancer in northern AlbertaP E Burns, K Freund, A W Lees, et al.
Chest|June 1, 1972
Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivationJ Smith, W F Tyrell, A Gow, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1982
Influence and significance of certain prognostic factors on survival in breast cancerA H Paterson, V P Zuck, O Szafran, et al.
The American Review of Respiratory Disease|January 1, 1972
Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosisA W Lees, G W Allan, J Smith, et al.
Surgery, Gynecology & Obstetrics|December 1, 1980
Oophorectomy versus radiation ablation of ovarian function in patients with metastatic carcinoma of the breastA W Lees, C Giuffre, P E Burns, et al.
Pageof 5